Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Scott Kopetz, Shannon L McDonough, Van Karlyle Morris, Heinz-Josef Lenz, Anthony Martin Magliocco, Chloe Evelyn Atreya, Luis A. Diaz, Carmen Joseph Allegra, Stephen E. Wang, Christopher Hanyoung Lieu, S. Gail Eckhardt, Thomas John Semrad, Kimberly Kaberle, Katherine A Guthrie, Howard S. Hochster
Institutions: The University of Texas MD Anderson Cancer Center, Fred Hutch Cancer Center, USC Norris Comprehensive Cancer Center, Moffitt Cancer Center, University of California, San Francisco, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Florida, Kaiser Permanente, Kaiser Permanente Sacramento Medical Center, University of Colorado Denver, University of Colorado Anschutz, University of California, Davis, SWOG Cancer Research Network, Yale Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4248090744